A Q and A career counselling column for students ...

Dr. Andrew Rhinehart Dr. Andrew “Andy” Rhinehart will serve as the new chief scientific and medical officer for Sansum ...

James Chalmers, MBChB, PhD, highlights the reassuring safety and tolerability profile of brensocatib in patients with non–cystic fibrosis bronchiectasis.

Last year, NuGen announced the expansion of its distribution network for the needle-free InsuJet injection device to Argentina, Chile, Costa Rica and Peru. "NuGen to research and develop new injection ...

IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...

A woman aged 62 years presents with shortness of breath. Her chest x-ray is interpreted as normal by an artificial intelligence (AI) triage system. The overworked resident, reassured by the system's ...

GTCR has proposed to sell off some assets to Integer Holdings Corp., a manufacturer of medical devices. That includes a ...

LONDON, GREATER LONDON, UNITED KINGDOM, August 21, 2025 /EINPresswire.com/ -- What Is The Leukemia Inhibitory Factor (LIF) Market Size And Growth? The market size for Leukemia Inhibitory Factor (LIF) ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of ...

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...